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TB Elimination
CDC’s Role in Preventing Extensively  
Drug-Resistant Tuberculosis (XDR TB)
The Centers for Disease Control and Prevention 
(CDC) is collaborating with other federal 
agencies and international partners to raise 
awareness and enhance strategies for TB 
prevention worldwide by 
 • Strengthening TB services for people living 
with HIV/AIDS
The President’s Emergency Plan for AIDS 
Relief (PEPFAR), through funding and 
technical support, helps host countries 
promote early access to anti-retroviral 
therapy (ART) among HIV-infected 
TB patients; strengthen laboratory 
infrastructure, including promotion of 
rapid adoption of new TB diagnostics 
(e.g., XpertMTB/RIF) to ensure early 
diagnosis and appropriate TB treatment; 
promote intensified TB case finding and 
linkage to TB diagnosis and treatment 
among people living with HIV/AIDS; and 
roll-out and scale-up of TB infection control 
best practices.  Through PEPFAR support, 
host countries are working through national 
Ministries of Health to improve patient 
management of co-infected patients to 
conduct surveillance for drug-resistant 
TB, and to strengthen monitoring and 
evaluation efforts.
 • Assembling and deploying outbreak 
response teams
Teams of subject matter experts from CDC 
are prepared to be rapidly deployed to help 
host country governments and the World 
Health Organization (WHO) when outbreaks 
occur or other needs are identified.
 • Improving access to TB drugs
As a founding member of the Green Light 
Committee, CDC helped to increase access 
to quality-assured, lower-cost second-line 
drugs to treat drug-resistant TB.  After 
the original Green Light Committee was 
decentralized in 2011, CDC continues to 
serve on regional Green Light Committees.
 • Developing international TB testing 
standards
These recommendations are being 
designed to ensure more accurate and rapid 
detection and treatment of drug-resistant 
TB. They will include standards for second-
line drug susceptibility testing, new anti-TB 
drugs, and better diagnostic testing.
 • Building capacity of health care providers
By providing technical support and training, 
CDC helps to build the capacity of frontline 
health care providers to diagnose and 
ensure completion of treatment, which aids 
in preventing drug resistance.
 • Reconvening the Federal TB Task Force
This task force was originally created to 
respond to the emergence of multidrug-
resistant tuberculosis (MDR TB) in the U.S. in 
the 1990s. In 2009, the Federal TB Task Force 
developed an action plan to combat XDR TB.
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 • Providing technical assistance to expand 
program capacity
CDC and partners are working directly with 
host countries to implement improved 
infection control measures, rapid case 
detection, effective treatment, and drug 
resistance surveillance.
 • Supporting TB communication and 
education efforts
Information on XDR TB is being 
disseminated regularly and widely. This 
information is regularly updated on the 
CDC and partner websites, as well as being 
presented at national and international 
conferences and events. 
 • Quantifying the magnitude and causes of 
XDR TB
CDC scientists, in collaboration with our 
international partners, quantified the 
prevalence of and risk factors for XDR TB 
at research sites in 9 countries.  Further 
analysis will provide the first data on the 
emergence of XDR TB among patients being 
treated for MDR TB.
Note: In addition to CDC, U.S. government 
partners include the President’s Emergency 
Plan for AIDS Relief (PEPFAR), United States 
Agency for International Development (USAID), 
Tuberculosis Control Assistance Program 
(TBCAP), and the National Institutes of Health 
(NIH). Other domestic partners include the 
National Tuberculosis Controllers Association 
(NTCA) and local and state TB programs. 
International partners include the World Health 
Organization (WHO), the Stop TB Partnership, 
the International Union Against Tuberculosis 
and Lung Disease (IUATLD), national TB 
programs, and ministries of health.
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